Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Edwards Lifesciences Corp Company Profile (NYSE:EW)

Consensus Ratings for Edwards Lifesciences Corp (NYSE:EW) (?)
Ratings Breakdown: 6 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $95.21 6.79% downside)

Current Analysts' Coverage Summary for Edwards Lifesciences Corp (NYSE:EW)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/25/2014Piper JaffrayBoost Price TargetOverweight$95.00 -> $120.00ViewTweet This Rating  Share This Rating on StockTwits
9/16/2014Canaccord GenuityBoost Price TargetBuy -> Buy$103.00 -> $114.00ViewTweet This Rating  Share This Rating on StockTwits
9/10/2014Sterne AgeeInitiated CoverageBuy$110.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2014ZacksReiterated RatingNeutral -> Neutral$104.00ViewTweet This Rating  Share This Rating on StockTwits
8/21/2014JMP SecuritiesBoost Price TargetOutperform$97.00 -> $120.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2014Stifel NicolausBoost Price Target$90.00 -> $100.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2014JPMorgan Chase & Co.Boost Price Target$78.00 -> $90.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2014CRT CapitalBoost Price Target$90.00 -> $100.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2014BMO Capital MarketsBoost Price Target$84.00 -> $89.00ViewTweet This Rating  Share This Rating on StockTwits
7/30/2014Deutsche BankReiterated RatingHold$81.00 -> $90.00ViewTweet This Rating  Share This Rating on StockTwits
7/30/2014BarclaysReiterated RatingEqual Weight$67.00 -> $73.00ViewTweet This Rating  Share This Rating on StockTwits
7/30/2014Northland SecuritiesBoost Price TargetOutperform$90.00 -> $100.00ViewTweet This Rating  Share This Rating on StockTwits
7/30/2014Jefferies GroupBoost Price TargetBuy$94.00 -> $100.00ViewTweet This Rating  Share This Rating on StockTwits
7/29/2014RBC CapitalBoost Price TargetSector Perform$70.00 -> $79.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2014Leerink SwannBoost Price Target$90.00 -> $93.00ViewTweet This Rating  Share This Rating on StockTwits
4/14/2014Wells Fargo & Co.UpgradeNeutral -> Buy$82.97 -> $90.00ViewTweet This Rating  Share This Rating on StockTwits
4/14/2014Bank of AmericaReiterated RatingHold$85.00ViewTweet This Rating  Share This Rating on StockTwits
3/25/2014TheStreetUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
2/20/2014BTIG ResearchInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
12/10/2013Citigroup Inc.Reiterated RatingBuy$75.00 -> $72.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013Northland Capital PartnersBoost Price TargetOutperform$74.00 -> $80.00ViewTweet This Rating  Share This Rating on StockTwits
7/8/2013Credit SuisseUpgradeNeutral -> OutperformViewTweet This Rating  Share This Rating on StockTwits
6/3/2013Goldman SachsReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/25/2013S&P Equity ResearchBoost Price TargetBuy$57.00 -> $80.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2013WunderlichLower Price TargetHold$98.00 -> $74.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2013Lazard LtdDowngradeBuy -> Neutral$100.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2013Janney Montgomery ScottInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
1/9/2013William BlairReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/1/2012 forward)
Discuss Edwards Lifesciences Corp